drugset / Trial / NCT00726687
Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
This is a phase 1b study of Indibulin in combination with Capecitabine in advanced solid tumors.
Timeline
- Start
- 2008-06
- Primary completion
- 2013-06
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 875 mg/m2 | Oral |
| Subject | Capecitabine | Small molecule | 1250 mg/m2 | Oral |
| Subject | indibulin | Small molecule | 400 mg | Oral |
| Subject | indibulin | Small molecule | 600 mg | Oral |